__NUXT_JSONP__("/drugs/Lefitolimod", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:b,chebiId:b,chemicalFormula:b,definition:"A synthetic oligonucleotide based on a proprietary double stem-loop immunomodulator design with potential immunostimulating activity. Lefitolimod binds to and activates intracellular Toll-like receptor 9 (TLR9) in monocytes\u002Fmacrophages, plasmacytoidal and myeloid dendritic cells (DCs), and natural killer (NK) cells, initiating immune signaling pathways and inducing T-helper 1 cell (Th1) production leading to the production of memory T cells and a Th1-mediated immune response. By activating the immune system, MGN1703 may attack tumor associated antigen (TAAs). TLR9 is a member of the TLR family, which plays a fundamental role in pathogen recognition and activation of innate immunity.",fdaUniiCode:"6SO72A12FN",identifier:"C94207",preferredName:a,semanticType:"Immunologic Factor",subclassOf:["C2139"],synonyms:["LEFITOLIMOD",a,"MGN-1703","MGN1703","dSLIM-30L1"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FLefitolimod",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Lefitolimod","","2021-10-30T13:47:43.093Z")));